Skip to main content

EN
ÍS

Forsíða

Forsíða

Þorvarður Jón Löve - Prófessor

Þorvarður Jón Löve

–

Heilbrigðisvísindasvið

Þorvarður Jón Löve

Prófessor

Aðsetur
Sturlugata 8
Tölvupóstur
thl [hjá] hi.is

Starfseining
Læknadeild

ORCID vefsíða
https://orcid.org/0000-0002-2680-6120
Rannsóknagátt – Þorvarður Jón Löve

Show Útgefið efni

2025

Deep immune cell profiling in blood and bone marrow of early stage monoclonal gammopathyBlood Cancer Journal
Approaching hypercalcemia in monoclonal gammopathy of undetermined significanceBlood

2024

Analysis of smoldering multiple myeloma according to the target of the monoclonal immunoglobulin of patientsHemaSphere
Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European CountriesArthritis Care and Research
Deciphering the genetics and mechanisms of predisposition to multiple myelomaNature Communications
Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined SignificanceAnnals of Internal Medicine
Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis – relationship with the reason for withdrawal from the previous treatmentJoint Bone Spine
Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitorsScandinavian Journal of Rheumatology
Monoclonal gammopathy of undetermined significance and the risk of thrombotic eventsBritish Journal of Haematology
Monoclonal gammopathy of undetermined significance with multiple paraproteinsHemaSphere
Patient-reported outcomes and PRO remission rates in 12,262 biologic-naïve patients with psoriatic arthritis treated with TNF-inhibitors in routine careThe Journal of rheumatology
Population-based screening cohort study reveals no association between monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), multiple myeloma (MM), and alopeciaArchives of dermatological research
Predictors of treatment outcomes for Hepatitis C infection in a nationwide elimination program in IcelandInternational Journal of Drug Policy
Prescription of non-steroidal anti-inflammatory drugs for patients with inflammatory arthritis decreases with the initiation of tumour necrosis factor inhibitor therapyScandinavian Journal of Rheumatology
Prior cancer and risk of monoclonal gammopathy of undetermined significanceHaematologica
The significance of free light-chain ratio in light-chain monoclonal gammopathy of undetermined significanceBlood Cancer Journal

2023

Long COVID in Icelandic ChildrenThe Pediatric infectious disease journal
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF-inhibitorRheumatology (Oxford, England)
Sex differences in the effectiveness of first-line tumor necrosis factor inhibitors in psoriatic arthritis; results from the EuroSpA Research Collaboration NetworkArthritis & rheumatology (Hoboken, N.J.)
Author Correction: Prevalence of smoldering multiple myeloma based on nationwide screeningNature Medicine
Commonalities and differences in set-up and data collection across European spondyloarthritis registries — results from the EuroSpA collaborationArthritis Research and Therapy
CorrectionBlood Cancer Journal
Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometryBlood Cancer Journal
Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohortsHaematologica
Immunophenotypic assessment of clonal plasma cells and B-cells in bone marrow and blood in the diagnostic classification of early stage monoclonal gammopathiesBlood Cancer Journal
Management of Nail Disease in Patients With Psoriatic ArthritisThe Journal of rheumatology
Physical and cognitive impact following SARS-CoV-2 infection in a large population-based case-control studyCommunications Medicine
Prevalence of smoldering multiple myeloma based on nationwide screeningNature Medicine
Strong site-specific association of pharyngeal cultures with the onset of psoriatic arthritis and psoriasis, regardless of pathogenRheumatology (Oxford, England)
Trends of perceived disruption in healthcare services during the pandemicEuropean Journal of Public Health
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritisAnnals of the Rheumatic Diseases
Comment onRheumatology (United Kingdom)

2021

Validity of chronic disease diagnoses in Icelandic healthcare registriesScandinavian Journal of Public Health
Cascade of care during the first 36 months of the treatment as prevention for hepatitis C (TraP HepC) programme in IcelandThe Lancet Gastroenterology and Hepatology
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaborationAnnals of the Rheumatic Diseases
Iceland screens, treats, or prevents multiple myeloma (iStopMM)Blood Cancer Journal
Illness severity and risk of mental morbidities among patients recovering from COVID-19BMJ Open
Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologicsRheumatology (United Kingdom)
Monoclonal gammopathy of undetermined significance and COVID-19Blood Cancer Journal
No One Will be Safe until Our Children are SafePediatric Infectious Disease Journal
Outpatient Use of Antimicrobials in Patients With Rheumatoid Arthritis Before and After Treatment With Tumor Necrosis Factor Inhibitors: A Nationwide Retrospective Cohort StudyACR Open Rheumatology
Prevalence, admission rates and hypoxia due to COVID-19 in patients with rheumatic disorders treated with targeted synthetic or biologic disease modifying antirheumatic drugs or methotrexateAnnals of the Rheumatic Diseases
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) MeetingThe Journal of rheumatology. Supplement
Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors - a Nordic cohort studyRheumatology (Oxford, England)
Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significanceEuropean Journal of Haematology
Cascade of care in the Treatment as Prevention for Hepatitis C programme in Iceland
Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritisRheumatology (Oxford, England)

2022

A patients’ perspective towards the injection devices for Humira® and Imraldi® in a Nationwide witching programFrontiers in Medicine
Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined SignificanceFrontiers in Immunology
Body surface area affected by psoriasis and the risk for psoriatic arthritisRheumatology (United Kingdom)
Defining new reference intervals for serum free light chains in individuals with chronic kidney diseaseBlood Cancer Journal
Does biologic therapy impact the development of PsA among patients with psoriasis?Annals of the Rheumatic Diseases
Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitorsRMD Open
High Rate of Hepatitis C Virus Reinfection Among Recently Injecting Drug Users:Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) MeetingThe Journal of rheumatology
Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European CountriesArthritis Care and Research
Risk Factors for Diagnosis of Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis, and Ankylosing SpondylitisJournal of Rheumatology
SARS-CoV-2 Infections in Icelandic ChildrenPediatric Infectious Disease Journal
Symptoms, physical measures and cognitive tests after SARS-CoV-2 infection in a large population-based case-control study
The first wave of COVID-19 and concurrent social restrictions were not associated with a negative impact on mental health and psychiatric well-beingJournal of Internal Medicine

2020

FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid diseaseNature
Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritisRheumatology (United Kingdom)
Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment - Results from 12 countries in EuroSpARheumatology (United Kingdom)

2019

Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligibleRMD Open

2018

Golimumab in the treatment of psoriatic arthritisExpert Review of Clinical Immunology
Infections and the risk of psoriatic arthritis among psoriasis patientsRheumatology International
Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritisEuropean Heart Journal
The majority of patients with psoriatic arthritis are not eligible for randomised clinical trialsClinical and Experimental Rheumatology
Treatment as Prevention for Hepatitis C (TraP Hep C) – a nationwide elimination programme in Iceland using direct-acting antiviral agentsJournal of Internal Medicine
„Það er fróðlegt og krefjandi að vinna í teymi“ Þverfræðilegt nám á heilbrigðisvísindas við iHáskóla Íslands: þriggja ára þróunarverkefniTímarit hjúkrunarfræðinga

2017

Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritisRheumatology (United Kingdom)
Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasisAnnals of the Rheumatic Diseases
The risk of fracture among patients with psoriatic arthritis and psoriasisAnnals of the Rheumatic Diseases

2016

Bloodstream infections in patients with chronic lymphocytic leukemiaAnnals of Hematology
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic ArthritisArthritis and Rheumatology
The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritisRheumatology (United Kingdom)

2015

Er þörf á sérstakri heilbrigðismóttöku fyrir háskólanemendur?Tímarit hjúkrunarfræðinga
Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritisAnnals of the Rheumatic Diseases

2014

Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritisRheumatology (United Kingdom)
Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritisAnnals of Internal Medicine
Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasisAnnals of the Rheumatic Diseases
Treatments for nail psoriasisJournal of Rheumatology
Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement networkPharmacoepidemiology and Drug Safety
Vísindastarf á LandspítalaLæknablaðið

2013

Prevalence and treatment patterns of psoriatic arthritis in the UKRheumatology (United Kingdom)

2012

Borrelia and subsequent risk of solid tumors and hematologic malignancies in SwedenInternational Journal of Cancer
Obesity and the risk of psoriatic arthritisAnnals of the Rheumatic Diseases
Psoriatic arthritis and onycholysis - Results from the cross-sectional reykjavik psoriatic arthritis studyJournal of Rheumatology
ReInternational Journal of Cancer

2011

Prevalence of the metabolic syndrome in psoriasisArchives of Dermatology
Validation of Psoriatic Arthritis Diagnoses in Electronic Medical Records Using Natural Language ProcessingSeminars in Arthritis and Rheumatism

2010

Laboratory tests in autoimmune disease.
Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasisAnnals of the Rheumatic Diseases
Small joint involvement in psoriatic arthritis is associated with onycholysisScandinavian Journal of Rheumatology
Update on Abatacept Therapy of RA.

2009

A 'pilot' study on air-travel and venous thromboembolismBritish Journal of Haematology
A strong heritability of psoriatic arthritis over four generations--the Reykjavik Psoriatic Arthritis Study.Rheumatology (Oxford, England)
Promotion and Regulation of Autoimmune Inflammation by B Cells.

2008

The relationship between cancer and rheumatoid arthritisArthritis Research and Therapy

2007

Psoriatic arthritis in Reykjavik, IcelandJournal of Rheumatology

2004

Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8 ⁺ T cellsClinical and Experimental Immunology

Sérsvið:

Gagnasafnsrannsóknir